About 2 600 reports

  • Increasing Awareness and Accessibility of Next-Generation Direct-Acting Antivirals (DAAs) to Expand the Market
  • HEPATITIS C THERAPEUTICS MARKET, AUSTRALIA, GESA HEPATITIS C TREATMENT GUIDELINES,

NS##/ ##A protease has been demonstrated to cleave adaptor molecule IPS-##, which inhibits RIG-I and MDA## signaling, and subsequently suppresses IFN-mediated antiviral gene expression.

  • Pharmaceutical
  • Bristol-Myers Squibb Company
  • Gilead Sciences, Inc.
  • Merck & Co., Inc.
  • Roche Group
  • GLOBAL ANTIVIRALS MARKET SIZE GAIN ($ BILLION), 2018 - 2022, BY SEGMENT
  • GLOBAL ANTIVIRALS MARKET, SEGMENTATION BY THERAPEUTIC TYPE, 2014-2022, $ BILLION

The details ##.

  • Pharmaceutical
  • World
  • Gilead Sciences, Inc.
  • GlaxoSmithKline plc
  • Merck & Co., Inc.
  • Antiviral
  • Competitive Assessment of Pipeline Antivirals

With antivirals, one of the problems is to demonstrate efficacy in populations really at risk.

  • Pharmaceutical
  • United States
  • Forecast
  • Novavax, Inc.
  • RSV LRTI group
  • 8.2.1 ANTIVIRALS
  • 7.4 ANTIVIRAL MONOTHERAPY OR COMBINATION THERAPY WITH IMPROVED EFFICACY AND

Oxford University Press, ## Suppl ##(Suppl ##), pp.

  • Pharmaceutical
  • Japan
  • United States
  • Atara Biotherapeutics, Inc.
  • Moderna Therapeutics, Inc.
  • Antivirals
  • Major Antivirals Disease Drugs Producer Facility Locations, Output (billion Yuan)and Market Share

What' s more, some intermediates for Antivirals drugs depend on imports in China' s Antivirals industry.

  • Pharmaceutical
  • China
  • CSPC Pharmaceutical Group Limited
  • Livzon Group
  • Zhejiang Expressway Co., Ltd.
  • 2.2 Pipeline Dominated by Direct-Acting Antivirals
  • 2.3 Diverse Range of Host-Targeting and Direct-Acting Antivirals in First-in-Class Pipeline

ANOTHER PHASE II STUDY INVOLVING ## HEPATITIS C PATIENTS WITH GENOTYPE ## WAS CONDUCTED TO ASSESS THE SAFETY AND ANTIVIRAL ACTIVITY OF THREE MONTH' S DOSING OF BIT-##.

  • Pharmaceutical
  • AbbVie Inc.
  • Bristol-Myers Squibb Company
  • Gilead Sciences, Inc.
  • Merck & Co., Inc.

In 2018, the antiviral segment had a significant market share, and this trend is expected to continue over the forecast period.

  • Pharmaceutical
  • Therapy
  • World
  • Forecast
  • 4.3 Expert Opinion
  • Spain Antiviral Drug Resistance Market Revenue and Forecasts to 2027 (US$ Mn)

Till date, there is no approved antiviral therapy for any of the emerging or re-emerging viral infections.

  • Pharmaceutical
  • World
  • Forecast
  • Market Size
  • Acon Laboratories, Inc
  • Antivirals
  • Anti-infectious Disease Drugs' Output by Drugs' Classification and Percent in 2018

Antivirals are used to treat infections caused by viruses.

  • Pharmaceutical
  • China
  • CSPC Pharmaceutical Group Limited
  • Livzon Group
  • North China Pharmaceutical Group Corp.
  • Antiviral resistance
  • MARKET CHALLENGES

For individuals expressing acyclovir-resistant HSV strains, different antiviral therapies are available.

  • Pharmaceutical
  • Gilead Sciences, Inc.
  • GlaxoSmithKline plc
  • Merck & Co., Inc.
  • Novartis AG

EXECUTIVE SUMMARY ##.

  • Antiviral
  • Pharmaceutical
  • APAC
  • Demand
  • Market Shares

Global Market Study on Elastomeric Infusion Pumps: Increasing Awareness about Evidence-backed Treatment to Improve Growth Prospects ##.

  • Pharmaceutical
  • APAC
  • North America
  • World
  • Market Size
  • Major Antivirals Disease Drugs Producer Facility Locations, Output (billion Yuan)and Market Share
  • Anti-infectious Disease Drugs' Output by Drugs' Classification and Percent in 2018

Antivirals are used to treat infections caused by viruses.

  • Pharmaceutical
  • China
  • CSPC Pharmaceutical Group Limited
  • Livzon Group
  • Zhejiang Expressway Co., Ltd.

Anti-infective Agents Market Analysis By Type (Antibacterial, Cephalosporins, Penicillins, Fluoroquinolones, Macrolides, Carbapenems, Antifungal, Azoles, Echinocandins, Polyenes, Antiviral) And Segment Forecasts To 2024 Table of Content Chapter ## Executive Summary Chapter ## Market

  • Anti-Infective
  • Pharmaceutical
  • Therapy
  • United States
  • Forecast

The two major HIV subtypes are HIV-## and HIV-##.

  • Antiviral
  • Pharmaceutical
  • Therapy
  • World
  • Market Shares
  • 6.6 OTHER BRANDED DIRECT-ACTING ANTIVIRALS
  • 6.4 MAJOR BRANDS - SINGLE COMPONENT DIRECT-ACTING ANTIVIRALS

Potent antiviral activities of the direct-acting antivirals ABT-## and ABT-## with three-day monotherapy for hepatitis C virus Genotype ## infection.

  • Pharmaceutical
  • Market Size
  • AbbVie Inc.
  • Gilead Sciences, Inc.
  • Janssen Biotech, Inc.

Based on product type the market is categorized into antibacterials, antifungals and antivirals.

  • Anti-Infective
  • Pharmaceutical
  • United States
  • Forecast
  • Market Size

This influence varies from one industry to another, but also from one period of time to another.

  • Antiviral
  • Pharmaceutical
  • Therapy
  • World
  • Demand

This influence varies from one industry to another, but also from one period of time to another.

  • Antiviral
  • Pharmaceutical
  • Therapy
  • World
  • Demand

Antiviral/ Anti JCV ##. ##. ##.

  • Pharmaceutical
  • Therapy
  • APAC
  • World
  • Market Size
  • COMMON PRESCRIPTION DERMATOLOGICAL SYSTEMIC AND TOPICAL ANTIVIRAL FORMULATIONS
  • MARKET SIZE AND GROWTH FOR ROW PRESCRIPTION MISCELLANEOUS SKIN DISORDER DRUG MARKET, 2016-2021 ($ MILLIONS)

THE LEADING COMPANY IN THE PRESCRIPTION DERMATOLOGICAL ANTIVIRAL MARKET IS PFIZER.

  • Pharmaceutical
  • World
  • Market Size
  • Galderma S.A.
  • Valeant Pharmaceuticals International, Inc.

Global Biosimilars and Follow-On Biologics Market 2019-2029 ## Report Overview ##. ## Biosimilar Overview ##. ## Biosimilars Market Segmentation ##. ## Why You Should Read this Report ##. ## How this Report Delivers ##. ## Main Questions Answered by this Report ##. ## Who is this Report for?

  • Medical Biotechnology
  • Pharmaceutical
  • World
  • Market Shares
  • Market Size
  • 6.3 GRAPE SEEDS
  • 6.3 GRAPE SEEDS

Tier ##: Revenue > USD ## billion; Tier ##: USD ## million ≤ Revenue ≤ USD ## billion; Tier ##: Revenue < USD ## million.

  • Pharmaceutical
  • World
  • Demand
  • Market Size
  • Naturex SA
  • Global Anti-infective Drugs Market, Split By Segments, 2017, $ Billion
  • Global Anti-infective Drugs Market, Split By Segments, 2017, $ Billion

ua=## lxiii http:/ / investors. gilead. com/ phoenix. zhtml?

  • Pharmaceutical
  • Forecast
  • Gilead Sciences, Inc.
  • GlaxoSmithKline plc
  • Merck & Co., Inc.

The Global Influenza Market Chapter ## Introduction Influenza Overview Study Goals and Objectives Reasons for Doing This Study Scope of Report Information Sources Methodology Geographic Breakdown Analyst’s Credentials Related BCC Research Reports Chapter ## Summary and Highlights The Influenz

  • Influenza
  • Pharmaceutical
  • Therapy
  • Vaccine
  • World
  • Untitled

RESEARCHERS ARE NOW TRYING TO DEFINE THE MECHANISM OF THE APPARENT ANTIVIRAL ACTION OF BHT AND EXTENDING THEIR ATTENTION TO OTHER VIRUSES USING BHT AND OTHER ANTIOXIDANTS.

  • Pharmaceutical
  • Archer Daniels Midland Company
  • Cargill Inc.
  • Koninklijke DSM N.V.
  • Nutreco N.V.

Antivirals Autoimmune Diseases Diabetes Emergency Medicine Hematopoietics Hormone Replacement Neurology Osteoporosis Reproductive Health Vaccines Market Factors Regulatory Issues Device Branding Patient Compliance Healthcare Economics Partnerships and Alliances Company Profiles & nbsp; &

  • Drug Delivery
  • Injectable Delivery
  • Pharmaceutical
  • Demand
  • 3.3 UPCOMING RELATED REPORTS

TABLE ##: PEDIATRIC VACCINATION RATE TRENDS IN EUROPE (%) ##. ##% ##. ##% ##. ##% Source: GlobalData; COVER, 2010-2018; MSS, 2010; MSS, 2012a-d; MSS, 2013a-b; MSS, 2014a-c; MSS, 2015a-b; MSS, 2016a-b; MSS, 2017ab; MSSSI, 2017; Rieck et al., 2014; Signorelli et al., 2018 *DT-IPV, ≥## doses, ## yea

  • Pharmaceutical
  • Japan
  • North America
  • Merck & Co., Inc.
  • Sanofi S.A.

Antivirals ##. ##. ##.

  • Pharmaceutical
  • Therapy
  • APAC
  • World
  • Market Size
  • CIPLA
  • MERCK & CO.

PRODUCT CATEGORIES: ANTIVIRALS.

  • Pharmaceutical
  • North America
  • World
  • Boehringer Ingelheim GmbH
  • Bristol-Myers Squibb Company